Potassium Iodide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Pharmaceutical is the fastest growing sector, Asia-Pacific is the largest market

The Global Potassium Iodide Market is projected to grow from USD 477.17 Million in 2025 to USD 635.44 Million by 2031, exhibiting a 4.89% Compound Annual Growth Rate. This stable metal-halide salt, composed of potassium and iodine, is widely used in pharmaceuticals, nutritional fortification, and industrial applications. Market expansion is primarily fueled by widespread government mandates for universal salt iodization to prevent thyroid-related disorders, its critical role in nuclear safety protocols for radiation protection, and the increasing need for iodine supplementation in animal feed and dietary products. For instance, the Iodine Global Network reported that effective fortification strategies had reduced the number of iodine-deficient countries in the World Health Organization European Region to just two by 2024, underscoring ongoing product necessity. However, the market faces significant challenges due to the volatility of raw material prices, as global iodine production is heavily concentrated in limited geographic regions, leaving the supply chain vulnerable to fluctuations and potential disruptions.

Market Drivers

Strategic stockpiling for nuclear radiation emergencies acts as a primary catalyst for the Global Potassium Iodide Market, driven by heightened geopolitical tensions and rigorous safety updates. Governments and health authorities are actively securing stable iodine supplies to protect populations from radioactive exposure, as evidenced by local initiatives like the Windsor-Essex County Health Unit distributing approximately 1,300 potassium iodide pill kits to residents within nuclear zones by September 2024. This proactive procurement sustains consistent demand for tablet formulations.

Furthermore, the rising prevalence of thyroid disorders and iodine deficiency significantly anchors market growth, with potassium iodide remaining a frontline therapeutic agent for managing thyroid health, essential for treating conditions like hyperthyroidism. The American Cancer Society estimated around 43,720 new cases of thyroid cancer in the United States alone for 2024. To meet this escalating consumption across medical and industrial sectors, producers like Iofina plc expanded annual iodine production by 13.4% to 634.1 metric tonnes in 2024.

Market Challenges

The volatility of raw material prices, resulting from the heavy geographic concentration of global iodine production, acts as a primary destabilizing force that restricts the growth of the potassium iodide market. Manufacturers' reliance on a steady stream of crude iodine is jeopardized by the centralization of the upstream supply in very few regions, with Chile accounting for approximately two-thirds of world iodine production in 2024, according to the U.S. Geological Survey (2025).

This lack of elasticity makes the supply chain vulnerable to disruptions from logistical bottlenecks, regulatory changes, or environmental issues, triggering immediate supply shortages and sharp cost increases. This unpredictability prevents potassium iodide producers from securing stable, long-term pricing contracts with clients, thereby reducing profit margins and deterring necessary capital investments. Consequently, the inability to diversify supply sources forces downstream buyers to operate cautiously, limiting inventory expansion and hampering the industry's capacity to meet rising demand in critical sectors like nuclear safety and nutrition.

Market Trends

Two significant trends are currently propelling the potassium iodide market. First, the synergistic application in Nylon 6,6 heat stabilization is driving demand as manufacturers utilize potassium iodide alongside copper salts to prevent thermal oxidation in polyamide components. This chemical interaction is essential for maintaining material integrity in high-temperature vehicle environments, making it a critical input for the automotive sector's shift toward lightweight engineering plastics. Global passenger car manufacturing, which totaled 75.5 million units in 2024 according to the European Automobile Manufacturers’ Association (March 2025), consistently fuels demand for these specialized heat-stabilized formulations.

Second, the emergence of clean label iodine nutraceuticals is reshaping consumption patterns, as consumers increasingly prioritize transparent, allergen-free dietary supplements. This shift drives the production of pharmaceutical-grade potassium iodide, which serves as a preferred, stable source of iodine for thyroid health and metabolic support in 'clean label' product lines. The commercial expansion of this segment is evidenced by Iofina plc's report in September 2025, which indicated that sales of its iodine derivatives rose by 16% to $9.2 million, reflecting a strengthening market appetite for specialized iodine-based formulations.

Key Market Players

• Adani Pharmachem P. Ltd.
• Nantong Lingang Chemical Co., Ltd.
• ZH Chemicals Pvt Ltd
• Infinium Pharmachem Pvt.
• Ascent Pharmaceuticals, Inc.
• HTKP INDUSTRIES PVT LTD
• Eskay iodine private limited
• Shandong Boyuan Pharmaceutical Co., Ltd.
• SAMRAT REMEDIES LTD
• Toyota Tsusho America Inc

Report Scope

In this report, the Global Potassium Iodide Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Potassium Iodide Market, by Sales Channel:

• Direct
• Indirect

Potassium Iodide Market, by End Use:

• Pharmaceutical
• Food Additives
• Industrial
• Laboratory & Analytical Uses
• Water Treatment & Disinfection
• Others

Potassium Iodide Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Potassium Iodide Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.